In March 2025, the company announced new programs for the immediate-to-buyer presenting of its Wegovy weight loss drug. The company founded a brand new pharmacy, referred to as NovoCare, which would cost clients $499 every month for access to the drug, less than half the cost of the drug as a result of other pharmaceutical distribution networks.[fi